Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
BARRY J BYRNE
Listed Specialty: Pediatric Cardiology
1600 SW ARCHER RD, GAINESVILLE, FL, 32610-3003
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
DR. BARRY BYRNE,
Yearly Payment Breakdown:
2018 Payments At a Glance
62
payments
$81,241
payment total
5
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
17 | $61,692 |
Promotional Speaking/Other |
5 | $10,246 |
Travel and Lodging |
20 | $7,614 |
Food and Beverage |
20 | $1,690 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
Payments with no listed product |
N/A |
$41,575 |
LUMIZYME |
drug |
$18,649 |
EXONDYS 51 |
drug |
$8,739 |
NO PRODUCT DISCUSSED |
drug |
$6,889 |
NON-COVERED PRODUCT |
drug |
$5,348 |
POMPE - DISEASE |
drug |
$41 |
XLSD |
drug |
$22 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Apr 23, 2018 | $15,000 | No Listed Product | Consulting | PFIZER INC. | |
| Apr 23, 2018 | $15,000 | No Listed Product | Consulting | PFIZER INC. | |
| Jun 21, 2018 | $7,800 | No Listed Product | Consulting | SHIRE NORTH AMERICAN GROUP INC | |
| Nov 16, 2018 | $6,500 | LUMIZYME | Promotional Speaking/Other | GENZYME CORPORATION | |
| Jul 27, 2018 | $5,413 | LUMIZYME | Consulting | GENZYME CORPORATION | |
| Mar 26, 2018 | $4,500 | EXONDYS 51 | Consulting | SAREPTA THERAPEUTICS, INC. | |
| Apr 17, 2018 | $3,323 | NO PRODUCT DISCUSSED | Consulting | GENZYME CORPORATION | |
| Oct 18, 2018 | $2,650 | EXONDYS 51 | Consulting | SAREPTA THERAPEUTICS, INC. | |
| Feb 7, 2018 | $1,608 | LUMIZYME | Promotional Speaking/Other | GENZYME CORPORATION | |
| May 9, 2018 | $1,551 | NO PRODUCT DISCUSSED | Consulting | GENZYME CORPORATION | |
| Jun 14, 2018 | $1,346 | LUMIZYME | Promotional Speaking/Other | GENZYME CORPORATION | |
| Apr 25, 2018 | $1,202 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Jul 27, 2018 | $1,166 | LUMIZYME | Travel and Lodging | GENZYME CORPORATION | |
| Nov 29, 2018 | $1,108 | NO PRODUCT DISCUSSED | Consulting | GENZYME CORPORATION | |
| Jun 30, 2018 | $1,063 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $1,008 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $944 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Oct 25, 2018 | $913 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Oct 25, 2018 | $913 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Sep 30, 2018 | $657 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Nov 16, 2018 | $580 | LUMIZYME | Travel and Lodging | GENZYME CORPORATION | |
| Jun 30, 2018 | $545 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Apr 12, 2018 | $503 | LUMIZYME | Promotional Speaking/Other | GENZYME CORPORATION | |
| Mar 10, 2018 | $424 | EXONDYS 51 | Travel and Lodging | SAREPTA THERAPEUTICS, INC. | |
| Jun 30, 2018 | $400 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Apr 24, 2018 | $377 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
| Sep 30, 2018 | $367 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $364 | NON-COVERED PRODUCT | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Nov 16, 2018 | $337 | LUMIZYME | Food and Beverage | GENZYME CORPORATION | |
| Nov 16, 2018 | $326 | LUMIZYME | Travel and Lodging | GENZYME CORPORATION | |
| Oct 25, 2018 | $297 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Apr 24, 2018 | $289 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
| Oct 1, 2018 | $289 | LUMIZYME | Promotional Speaking/Other | GENZYME CORPORATION | |
| Mar 10, 2018 | $289 | EXONDYS 51 | Travel and Lodging | SAREPTA THERAPEUTICS, INC. | |
| Mar 10, 2018 | $263 | EXONDYS 51 | Travel and Lodging | SAREPTA THERAPEUTICS, INC. | |
| Aug 9, 2018 | $260 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| Jul 27, 2018 | $170 | LUMIZYME | Travel and Lodging | GENZYME CORPORATION | |
| Oct 30, 2018 | $158 | EXONDYS 51 | Food and Beverage | SAREPTA THERAPEUTICS, INC. | |
| Jul 27, 2018 | $140 | LUMIZYME | Food and Beverage | GENZYME CORPORATION | |
| Mar 9, 2018 | $124 | EXONDYS 51 | Food and Beverage | SAREPTA THERAPEUTICS, INC. | |
| Jan 31, 2018 | $122 | EXONDYS 51 | Food and Beverage | SAREPTA THERAPEUTICS, INC. | |
| May 9, 2018 | $102 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
| Apr 25, 2018 | $101 | No Listed Product | Food and Beverage | PFIZER INC. | |
| Jun 26, 2018 | $96 | EXONDYS 51 | Food and Beverage | SAREPTA THERAPEUTICS, INC. | |
| Jul 27, 2018 | $64 | LUMIZYME | Food and Beverage | GENZYME CORPORATION | |
| May 9, 2018 | $51 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
| Apr 25, 2018 | $50 | No Listed Product | Food and Beverage | PFIZER INC. | |
| Mar 10, 2018 | $50 | EXONDYS 51 | Food and Beverage | SAREPTA THERAPEUTICS, INC. | |
| Mar 10, 2018 | $50 | EXONDYS 51 | Food and Beverage | SAREPTA THERAPEUTICS, INC. | |
| Jul 27, 2018 | $45 | LUMIZYME | Food and Beverage | GENZYME CORPORATION | |
| Jul 27, 2018 | $45 | LUMIZYME | Food and Beverage | GENZYME CORPORATION | |
| Jul 27, 2018 | $45 | LUMIZYME | Food and Beverage | GENZYME CORPORATION | |
| Nov 16, 2018 | $40 | LUMIZYME | Travel and Lodging | GENZYME CORPORATION | |
| Aug 20, 2018 | $38 | No Listed Product | Travel and Lodging | PFIZER INC. | |
| May 9, 2018 | $36 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
| May 9, 2018 | $33 | NO PRODUCT DISCUSSED | Food and Beverage | GENZYME CORPORATION | |
| Jul 27, 2018 | $31 | LUMIZYME | Travel and Lodging | GENZYME CORPORATION | |
| May 8, 2018 | $22 | POMPE - DISEASE XLSD | Food and Beverage | GENZYME CORPORATION | |
| Apr 12, 2018 | $19 | POMPE - DISEASE | Food and Beverage | GENZYME CORPORATION | |
| Apr 24, 2018 | $17 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION | |
| Mar 10, 2018 | $14 | EXONDYS 51 | Travel and Lodging | SAREPTA THERAPEUTICS, INC. | |
| Apr 24, 2018 | $4 | NO PRODUCT DISCUSSED | Travel and Lodging | GENZYME CORPORATION |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.